Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Recruiting Observational

Correlation Between Psychological Readiness, Knee Function, and Isokinetic Performance After Anterior Cruciate Ligament Reconstruction (ACLR) Using Peroneus Longus Tendon Graft (PL-ACL-2025)

NCT07201597 · tracked via the Priya Life Science Egypt tracker
Phase
Observational
Started
2025-10-08
Last updated
2025-10-01

Condition(s) studied

Anterior Cruciate Ligament (ACL) InjuryAthletic InjuriesKnee Injuries

Study summary

This clinical trial aims to investigate the correlation between psychological readiness, knee function, and isokinetic performance after anterior cruciate ligament reconstruction (ACLR) using the Peroneus Longus tendon graft (PLT). ACL injuries are common among athletes, and the standard treatment is ACL reconstruction surgery (ACLR). However, the success of the surgery does not solely depend on physical recovery but also on the psychological readiness of athletes to return to their sport.

This study focuses on athletes who have undergone ACLR using the Peroneus Longus tendon (PLT). The primary objective is to compare psychological readiness, self-reported knee function (IKDC score), isokinetic performance (quadriceps and hamstring strength), and muscle strength ratios between athletes who meet return-to-sport (RTS) criteria and those who do not.

Psychological readiness will be assessed using the ACL-Return to Sport after Injury (ACL-RSI) scale, while knee function will be evaluated using the IKDC subjective score. Isokinetic testing will assess quadriceps and hamstring strength at various angular velocities. This study aims to provide a more comprehensive understanding of the factors influencing an athlete's ability to return to sport after ACLR, combining both physical and psychological aspects.

The results will help optimize rehabilitation strategies by offering a multidimensional approach, considering both physical and psychological factors, to improve recovery protocols for ACL-injured athletes.

Eligibility

Sex
MALE
Min age
18 Years
Max age
35 Years
Healthy volunteers
No
Inclusion Criteria: * Male recreational athletes aged 18-35 years. * Participation in sports that involve deceleration, jumping, cutting, or turning (e.g., basketball, soccer, volleyball). * Primary unilateral ACL injury treated with ACL reconstruction using a Peroneus Longus autograft. * Single evaluation 6-12 months after ACL reconstruction. * Completed a standardized postoperative rehabilitation program for ≥6 months, with near-complete rehabilitation and some level of sport participation. * Sufficient knee confidence, no effusion/edema, full knee range of motion, and able to perform all functional tests safely. * Able to provide written informed consent. Exclusion Criteria: * Revision ACL reconstruction. * Prior ACL reconstruction on the ipsilateral or contralateral knee. * Multi-ligament knee injury. * Concomitant meniscal repair or bilateral ACL reconstruction. * Knee pain \> 3/10 at evaluation that prevents or impairs testing. * Incomplete knee extension or knee flexion \< 110°. * Lower-limb fracture or surgery within the past 6 months.

Primary outcome measure(s)

  • Psychological Readiness to Return to Sport — Up to 9 months post-operative
    Psychological readiness to return to sport measured by the validated Arabic version of the ACL-Return to Sport after Injury (ACL-RSI). Total score 0-100; higher scores indicate greater psychological readiness.
  • Isokinetic Strength Performance (Quadriceps Strength at Various Velocities) — Up to 9 months post-operative
    This measure evaluates quadriceps strength at 60°/s, 120°/s, and 240°/s using the HUMAC NORM Isokinetic Dynamometer. It assesses peak torque and average power production in both the injured and uninjured limbs.

Trial sites (1)

FacilityCityRegionStatus
AHUC Cairo Cairo Governorate Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07201597 on ClinicalTrials.gov ↗ ← All trials in Egypt